Penbutolol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol | |
| Clinical data | |
| Trade names | Levatol |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a601091 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 36507-48-9 |
| ATC code | C07AA23 |
| PubChem | CID 37464 |
| DrugBank | DB01359 |
| ChemSpider | 34369 |
| UNII | 78W62V43DY |
| KEGG | D08074 |
| ChEMBL | CHEMBL1290 |
| Chemical data | |
| Formula | C18H29NO2 |
| Mol. mass | 291.428 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Penbutolol (Levatol, Levatolol, Lobeta, Paginol, Hostabloc, Betapressin) is a medication in the class of beta blockers, used in the treatment of high blood pressure.
[edit] References
[edit] External links
|
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |

